By Mitchell Labiak2019-03-04T12:43:00
The European Medicines Agency (EMA) has been given permission to appeal the High Court’s decision against it last month.
Permission for the case to be heard at the Court of Appeal was granted on all grounds. It will be heard at the Court of Appeal and is on the question of whether Brexit amounts to the ‘frustration’ of the European Medicines Agency’s 25-year, £500m lease at Canary Wharf.
You must be logged in to view premium stories.
Take out a print and online or online only subscription and you will get immediate access to:
To get access to premium content subscribe today
Alternatively REGISTER for a free trial to access up to 4 articles and sign up for email alerts